| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026762 |
| Receipt No. | R000030724 |
| Official scientific title of the study | Clinical usefulness of pulse oxi-capnometer, CapnoEye: a multicenter, non-randomized, open -label study for monitoring of EtCO2 in patients with respiratory disease. |
| Date of disclosure of the study information | 2017/03/30 |
| Last modified on | 2018/01/26 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Clinical usefulness of pulse oxi-capnometer, CapnoEye: a multicenter, non-randomized, open -label study for monitoring of EtCO2 in patients with respiratory disease. | |
| Title of the study (Brief title) | Clinical usefulness of pulse oxi-capnometer, CapnoEye. | |
| Region |
|
|
| Condition | ||
| Condition | Respiratory disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the clinical usefulness of pulse oxi-capnometer, CapnoEye, in patients with respiratory disease by calculating correlation coefficient between PaCO2 and EtCO2. |
| Basic objectives2 | Others |
| Basic objectives -Others | Correlation of PaCO2 and EtCO2 |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | To evaluate the performance of CapnoEye by calculating correlation coefficient between PaCO2 measured with arterial blood gas and EtCO2 measured by CapnoEye.
|
| Key secondary outcomes | - The explorative sub-group analysis for tendency (high vs low PaCO2, obstructive/restrictive/mixed disease, relationship with respiration rate)
- Safety data (medical device malfunction, adverse events). |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients whose PaCO2 is to be monitored and who agree to measure their EtCO2 simultaneously.
2. Patients who can understand the clinical study and who agree to participate in the study with the written informed consent. 3. Patients aged between 20 years and 85 years old. Or patients aged 16 years or over and less than 20 years at the time of Informed Consent with consent by legal representatives. 4. Inpatients or outpatients with respiratory / ventilatory dysfunction that range from mild to severe, who are able to follow the investigator's instructions. |
|||
| Key exclusion criteria | 1. Patients who are unable to take continuous mouth-breaths at least 8 cycles.
2. Patients who are unable to understand investigator's instructions, e.g. dementia and psychiatric disease. 3. Patients who undergo with Photo Dynamic Therapy and/or defibrillator as combination therapy. 4. Any other cases who are considered as inappropriate for the study by the investigators. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Toshio Ichiwata |
| Organization | Tokyo Medical University, Hachioji Medical Center |
| Division name | Respiratory Medicine |
| Address | 1163 Tatemachi, Hachioji, Tokyo |
| TEL | 042-665-5611 |
| ichiwata@tokyo-med.ac.jp | |
| Public contact | |
| Name of contact person | Toshio Ichiwata |
| Organization | Tokyo Medical University, Hachioji Medical Center |
| Division name | Respiratory Medicine |
| Address | 1163 Tatemachi, Hachioji, Tokyo |
| TEL | 042-665-5611 |
| Homepage URL | |
| ichiwata@tokyo-med.ac.jp | |
| Sponsor | |
| Institute | Tokyo Medical University, Hachioji Medical Center
Respiratory Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Precision Instruments Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | ・東京医科大学八王子療センター(東京都/Tokyo Medical University, Hachioji Medical Center
・東北大学病院(宮城県)/Tohoku University Hospital ・八尾徳洲会総合病院(大阪府)/Yao Tokushukai general hospital |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | - The correlation between PaCO2 measured by arterial blood gas analyzer invasively and EtCO2 measured by pulse oxi-capnometer, CapnoEye, which was investigational device was studied.
- Sixty patients in total were enrolled, with age 67.4+/-14.1 (mean+/-SD), 37 (61.7%) males and 23 (38.3%) females. - Their primary diseases are COPD for 21 cases (35.0%), asthma 5 (8.3%), idiopathic interstitial pneumonia 13 (8.3%), and others 26 (43.3%). - Correlation coefficient between PaCO2 and EtCO2 for patients of per protocol set (PPS, n=59) was r=0.815 and its regression line formula was y=1.065x - 4.783 (95% CI 0.864 - 1.266) (p<0.001). - Sub-analysis for PPS showed that high level of correlation coefficient between PaCO2 and EtCO2 was observed in groups of gender, age, inpatient or outpatient, and various type of respiratory diseases. - The study also suggested that correlation between respiration rate and EtCO2 was not clear, and an appropriate pattern of breathing rhythm for each individual patient could effect the accuracy of CapnoEye. - No adverse event and malfunction was observed. - Usefulness of CapnoEye in various respiratory disease care would be expected not only for inpatient but also outpatient as home-care equipment. |
| Other related information | The inpatient or outpatient of the institute is regarded as a candidate for the subject.
Parameters recorded by CapnoEye are EtCO2, SpO2, respiratory rate and pulse rate. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030724 |